Cite
HARVARD Citation
Morabito, F. et al. (n.d.). Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment. Leukemia research. 39 (8), pp. 840-845. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morabito, F. et al. (n.d.). Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment. Leukemia research. 39 (8), pp. 840-845. [Online].